Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105:493–510.
2. Suzuki Y, Yamamoto T, Araie M, Iwase A, Tomidokoro A, Abe H, et al. Tajimi Study review. Nippon Ganka Gakkai Zasshi. 2008;112:1039–58. (in Japanese).
3. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53(Suppl1):S3–10.
4. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13; discussion 829–30.
5. Heijl A, Leske MC, Bengtsson B, Bengtsson B, Hussein M. Early Manifest Glaucoma Trial Group. Measuring visual field progression in the early manifest Glaucoma trial. Acta Ophthalmol Scand. 2003;81:286–93.